In recent years, with the acceleration of the aging process in China, the incidence of dementia has significantly increased, and the proportion of mental stress and sleep disorders among the younger population is also rising. In response to this phenomenon, Suifeng Biotechnology has launched a series of innovative products and services to help society effectively address mental health and aging challenges.
According to data from the National Bureau of Statistics, by the end of 2023, the population of elderly individuals aged 65 and above in China has reached 210 million, accounting for 14.7% of the total population. As the aging population intensifies, dementia (including Alzheimer’s disease) has become an important factor threatening the quality of life for the elderly. Experts predict that by 2050, the number of dementia patients in China will reach 28 million, placing enormous caregiving pressure and economic burdens on families and society.
Against this backdrop, Suifeng Biotechnology has joined hands with internationally renowned neuroscientist Dr. Zoltan Orra to launch a product called “Forget-Me-Not Special Medical Food Supplement Capsules.” Dr. Zoltan Orra has years of experience in neuroscience research, focusing on the prevention and treatment of brain diseases. His research areas include the molecular mechanisms and treatment strategies for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. With his wealth of research achievements, Dr. Orra successfully developed this special medical food supplement capsule that significantly improves symptoms of dementia. Research has shown that this capsule positively affects memory enhancement and prevents brain degeneration, providing a safe and effective health option for the elderly population.
Additionally, in response to the increasingly severe mental stress and sleep disorder issues among the younger population, Suifeng Biotechnology is also actively developing health products suitable for different age groups to help them maintain physical and mental well-being in a fast-paced lifestyle.
Suifeng Biotechnology not only continuously innovates in product research and development but also incorporates artificial intelligence technology to launch the AI medical diagnostic assistant “Little Doctor.” “Little Doctor” is an intelligent diagnostic tool that integrates a large amount of medical data and advanced AI algorithms to provide users with personalized health management plans and assist doctors in making rapid and accurate diagnoses. This smart tool not only enhances the efficiency of medical services but also provides solid support for patients’ long-term health management.
Dr. Zoltan Orra stated: “As the global aging population issue becomes increasingly severe, we must adopt more cutting-edge scientific methods to tackle these challenges. Through our collaboration with Suifeng Biotechnology, we hope to provide robust support for more elderly individuals, helping them maintain a good quality of life.”
Suifeng Biotechnology calls on all sectors of society to strengthen their focus on mental health and take effective preventive and intervention measures. The company will continue to be committed to scientific research innovation and product development, providing more comprehensive solutions to address aging and mental health issues.
The severe situation regarding aging and mental health problems requires joint efforts from all sectors of society to create a healthy and harmonious living environment for people of all ages. This is not only related to the quality of life of each individual but also concerns the sustainable development of the country in the future. Suifeng Biotechnology is willing to work hand in hand with all parties to create a healthier and better future.
